UK markets closed
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • FTSE 250

    18,636.98
    -29.82 (-0.16%)
     
  • AIM

    875.21
    -1.01 (-0.12%)
     
  • GBP/EUR

    1.1607
    -0.0004 (-0.03%)
     
  • GBP/USD

    1.2116
    -0.0060 (-0.49%)
     
  • BTC-GBP

    15,955.32
    -79.77 (-0.50%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • DOW

    31,097.26
    +321.86 (+1.05%)
     
  • CRUDE OIL

    108.46
    +0.03 (+0.03%)
     
  • GOLD FUTURES

    1,811.30
    +9.80 (+0.54%)
     
  • NIKKEI 225

    25,935.62
    -457.38 (-1.73%)
     
  • HANG SENG

    21,859.79
    -137.11 (-0.62%)
     
  • DAX

    12,813.03
    +29.23 (+0.23%)
     
  • CAC 40

    5,931.06
    +8.20 (+0.14%)
     

Clariant reports markedly stronger sales growth and EBITDA expansion in Q1 2022

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·7-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Clariant International Ltd
Clariant International Ltd

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

 

  • First quarter 2022 sales from continuing operations increased by 30 % in local currency and 26 % in Swiss francs to CHF 1.262 billion pricing contributed 16 % to the strong top-line growth

  • Continuing operations EBITDA was up 27 % to CHF 220 million

  • EBITDA margin increased to 17.4 % from 17.3 % in the first quarter of 2021

  • First quarter performance underlines the ability to achieve mid-term targets

  • Outlook 2022: Strong local currency growth for the Group with the aim to improve
    year-on-year Group EBITDA margin level in a challenging geopolitical environment

“I’m proud to announce that Clariant had a strong start to 2022 despite the turbulent environment. In the first quarter, we successfully generated compelling revenue growth and clearly increased absolute EBITDA. The Group’s higher-value specialty portfolio once again enabled us to successfully manage continued variable cost inflation arising from raw materials, energy, and logistics services,” said Conrad Keijzer, CEO of Clariant. “Although the short-term macroeconomic uncertainty remains high, we are well on track to deliver on our mid-term targets.”

Key Financial Data

Continuing operations

 

 

First Quarter

in CHF million

 

 

 

 

 

2022

2021

% CHF

% LC

Sales

 

 

 

 

 

1 262

1 002

26

30

EBITDA

 

 

 

 

 

220

1731

27

 

- margin

 

 

 

 

 

17.4 %

17.3 %

 

 

EBITDA before exceptional items

 

 

 

 

 

238

1781

34

 

- margin

 

 

 

 

 

18.9 %

17.8 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 restated

First Quarter 2022 Very strong sales growth

MUTTENZ, JUNE 15, 2022

Clariant, a focused, sustainable, and innovative specialty chemicals company, today announced first quarter 2022 continuing operations sales of CHF 1.262 billion, compared to CHF 1.002 billion in the first quarter of 2021. This corresponds to a particularly strong increase of 30 % in local currency and 26 % in Swiss francs. The positive pricing impact of 16 % in part addressed continued cost inflation and also slightly outpaced the volume growth of 14 %. Care Chemicals and Natural Resources grew sales at an accelerated pace, which more than compensated for the expected slightly weaker development in Catalysis.

All geographic regions contributed meaningfully to the sales expansion in the first quarter of 2022, reflecting both continued strong demand as well as supply chain shortages. In Europe, the high 27 % local currency growth was underpinned by strong expansion in Care Chemicals as well as Natural Resources. Sales in Asia-Pacific rose by 31 %, underpinned by expansion in all Business Areas and clearly driven by 34 % higher sales in China. The Americas reported compelling growth as North American sales increased by a resounding 37 %, followed closely by Latin America at 31 %. In the Middle East & Africa, sales rose by 26 %.

In the first quarter of 2022, Care Chemicals increased sales by 44 % in local currency. This progress was supported by double-digit expansion in both Consumer Care and Industrial Applications, in particular Personal Care, Crop Solutions, Aviation, and Coatings. The consolidation of the acquired majority share in Clariant IGL Specialty Chemicals (CISC) and the acquisition of the remaining shares in Beraca further supported this positive development with an addition of 4 % local currency volume growth for the Group. Catalysis sales decreased by a slight 1 % in local currency, despite significantly higher Specialty Catalysts sales, which could not entirely counterbalance the weakness in parts of Petrochemicals and Syngas. Natural Resources sales increased by a resounding 31 % in local currency with growth attributable to all three Business Units, especially Additives.

The continuing operations EBITDA increased to CHF 220 million with a corresponding margin of 17.4 %, slightly exceeding the 17.3 % reported in the first quarter of the previous year. The increase was underpinned by operating leverage from higher sales, cost savings (CHF 4 million savings from efficiency programs), and pricing measures, which largely offset raw material price increases, supply chain constraints, and higher energy and logistics cost. The absolute EBITDA increased by a notable 27 %.

Discontinued Operations

Clariant’s Pigments business was divested to a consortium comprising Heubach Group and SK Capital Partners on 3 January 2022, which resulted in a provisional pretax disposal gain of CHF 168 million and an EBITDA of CHF 160 million for discontinued operations. Total Group (continuing operations and discontinued operations) EBITDA was CHF 380 million in the first quarter of 2022.

Outlook – Full Year 2022

Clariant aims to grow above the market to achieve higher profitability through sustainability and innovation. The Group concluded the final step in its significant portfolio transformation in January of 2022. Clariant is now a truly specialty chemicals company and confirms its 2025 ambition to deliver profitable growth (4 – 6 % CAGR), a Group EBITDA margin between 19 – 21 %, and a free cash flow conversion of around 40 %.

In the second quarter of 2022, Clariant expects to generate continued strong sales growth in local currency versus the prior year, underpinned by expansion in all Business Areas despite a normalizing growth environment. Sequential sales are expected to decline moderately as a result of seasonal impacts (aviation, refinery) and demand normalization in Care Chemicals and Natural Resources. Clariant expects to improve on its restated year-on-year margin levels in the second quarter of 2022. Sequentially, the Group expects to be broadly in line with its first quarter 2022 margin level, especially via operating leverage from growth, continuing pricing actions, and cost discipline to counter continued inflation in raw materials, logistics, labor, and energy cost.

For the full year 2022, Clariant expects strong growth in local currency for the Group, driven by a particularly strong first half of 2022. The current high level of uncertainty resulting from the geopolitical conflicts, suspension of business with Russia, and the resurgence of COVID-19 in China are expected to continue to impact global economic growth and consumer demand in the second half of the year. Clariant expects the high inflationary environment with regard to raw material, energy, and logistics cost as well as supply chain challenges to persist in the second half of 2022. Clariant aims to improve its year-on-year Group EBITDA margin levels via solid revenue growth driven by pricing and continued cost discipline, despite the increasingly challenging economic environment.

Q1 2022 Media Release EN

CORPORATE MEDIA RELATIONS

 

Jochen Dubiel
Phone +41 61 469 63 63
jochen.dubiel@clariant.com

 

Anne Maier
Phone +41 61 469 63 63
anne.maier@clariant.com

 

Ellese Caruana
Phone +41 61 469 63 63
ellese.caruana@clariant.com

INVESTOR RELATIONS

 

Andreas Schwarzwälder
Phone +41 61 469 63 73
andreas.schwarzwaelder@clariant.com

 

Maria Ivek
Phone +41 61 469 63 73
maria.ivek@clariant.com

 

Alexander Kamb
Phone +41 61 469 63 73
alexander.kamb@clariant.com

Follow us on Twitter, Facebook, LinkedIn, Instagram.

 

This media release contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.

 

www.clariant.com

 

 

Clariant is a focused, sustainable, and innovative specialty chemical company based in Muttenz, near Basel/Switzerland. On 31 December 2021, Clariant totaled a staff number of 11 537 and recorded sales of CHF 4.372 in the fiscal year for its continuing businesses. The company reports in three business areas: Care Chemicals, Catalysis and Natural Resources. Clariant’s corporate strategy is led by the overarching purpose of ‘Greater chemistry – between people and planet,’ and reflects the importance of connecting customer focus, innovation, sustainability, and people.

 


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting